Date Title Statement Presentation Report Webcast
14 September 2018

Wedbush Investor Conference Presentation

  Presentation    
26 June 2018

Circular - Allotment and disapplication of pre-emption rights

Statement      
26 March 2018

Phase 2b COPD four week study top-line data presentation

  Presentation    
9 March 2018

2018 AGM notice

Statement      
9 March 2018

Annual report 2017

    Report  
13 February 2018

Investor presentation

  Presentation    
7 September 2017

Top-Line Data from Phase 2a Clinical Trial in COPD with RPL554 Dosed in Addition to Tiotropium (Spiriva®)

  Presentation    
14 August 2017

Investor presentation, August 2017

  Presentation    
20 March 2017

2017 AGM Notice

Statement      
27 February 2017

Annual report 2016

    Report  
Close

Verona Pharma plc
3 More London Riverside, London SE1 2RE
T: +44 (0)203 283 4200

Linkedin     Email Us